Revvity Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Revvity Inc trades at $110.1 (market cap $11.87B), while State Street Real Estate Select Sector SPDR ETF trades at $45.34. The key difference: Revvity Inc pays a 0.26% dividend while State Street Real Estate Select Sector SPDR ETF pays none, and State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Revvity Inc nearer its low. Which is the better fit depends on your goals.
| RVTY | XLRE | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $117.75 | $45.46 |
52-Week Low | $82.26 | $40.01 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23 with a slight 0.42% decline. Technical indicators show a bullish trend with strong moving average support, though RSI suggests potential overbought conditions. The ETF has gained 11% year-to-date, benefiting from REIT sector recovery despite interest rate volatility. Recent news highlights XLRE's low 0.08% expense ratio advantage and steady dividend yield around 3.4%.
Outlook remains cautiously optimistic as REIT fundamentals improve with stable NOI growth and potential M&A activity. Key risks include interest rate sensitivity and inflation pressures. Wall Street sentiment is positive with the sector showing resilience amid broader market volatility, though investors should monitor Fed policy shifts that could impact real estate valuations.
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →